Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2

Biomedicine and Pharmacotherapy

Volumn 52, Issue 10, 1998, Pages 447-453

  Ylisastigui, L ^a   Amzazi, S ^a,b   Bakri, Y ^a,b   Vizzavona, J ^c   Vita, C ^c   Gluckman, J C ^a   Benjouad, A ^a,b,d  

^a SORBONNE UNIVERSITÉ   (France)

^b FACULTÉ DES SCIENCES   (Morocco)

^c CEA SACLAY   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

HIV 1; HIV 2; Macrophages; RANTES

Indexed keywords

ALPHA CHEMOKINE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; RANTES;

ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0032311204     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80023-7     Document Type: Article

References (41)

1. 1 Alkhatib G, Locati M, Kennedy PE, Murphy PM, Berger EA. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 1997 ; 234 : 340
2. 2 Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM et al. CC CKR-5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996 ; 272 : 1955
3. 3 Amara A, Le Gall S, Schwartz O, Salamero J, Montes M, Loetscher P et al. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997 ; 186 : 139
4. 4 Arenzana-Seisdedos A, Virelizier JL, Rousset D, Clark-Lewis I, Loescher P, Moser B et al. HIV blocked by chemokine antagonist. Nature 1996 ; 383 : 400
5. 5 Asjö B, Morfeldt-Manson L, Albert LJ, Biberfeld G, Karison A, Lindman K et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986 ; 2 : 660
6. 6 Baggiolini M, Moser B. Blocking chemokine receptors. J Exp Med 1997 ; 186 : 1189
7. 7 Benjouad A, Seddiki N, Ylisastigui L, Gluckman JC. HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages. AIDS Res Hum Retroviruses 1997 ; 13 : 219
8. 8 Benjouad A, Gluckman JC, Rochat H, Montagnier L, Bahraoui E. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol 1992 ; 66 : 2473
9. 9 Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996 ; 382 : 829
10. 10 Bron R, Klasse PJ, Wilkinson D, Clapham PR, Pelchen-Matthews A, Power C et al. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by human immunodeficiency virus type 2 envelope protein. J Virol 1997 ; 71 : 8405
11. 11 Capobianchi MR, Abbate I, Antonelli G, Turriziani O, Dolei A, Dianzani F. Inhibition of HIV type 1 BaL replication by MIP-1 alpha, MIP1-beta, and RANTES in macrophages. AIDS Res Hum Retroviruses 1998 ; 14 : 233
12. 12 Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997 ; 387 : 183
13. + T cells. Science 1995 ; 270 : 1811
14. 14 Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997 ; 185 : 621
15. 15 Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996 ; 381 ; 661
16. 16 Di Marzio P, Tse J, Landau NR. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Hum Retroviruses 1998 ; 14 : 129
17. 17 Doranz BJ, Rucker J, Yi Y, Smyth R, Samson M, Peiper SC et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996 ; 85 : 1149
18. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996 ; 381 : 667
19. 19 Enders MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A et al. CD4-independent infection by HIV-2 is mediated by Fusin/CXCR4. Cell 1996 ; 87 : 745
20. 20 Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996 ; 272 : 872
21. 21 Gartner S, Popovic M. Macrophage tropism of HIV-1. AIDS Res Hum Retroviruses 1990 ; 8 : 1017
22. 22 Marlink R. Lessons from the second AIDS virus. HIV-2. AIDS 1996 ; 10 : 689
23. 23 Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Ann Rev Immunol 1990 ; 8 : 169
24. + T-cell-derived soluble factor(s), but not β chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocytes/macrophages. Proc Natl Acad Sci USA 1996 ; 93 : 15341
25. 25 Naif HM, Li S, Alali M, Sloane A, Wu L, Kelly M et al. CCR5 expression correlates with susceptibility of maturating monocytes to human immunodeficiency virus type 1 infection. J Virol 1998 ; 72 : 830
26. 26 Oravecz T, Pall M, Wang J, Roderiquez G, Ditto M, Norcross MA. Regulation of anti-HIV-1 activity of RANTES by heparin sulfate proteoglycans. J Immunol 1997 ; 159 : 4587
27. -independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 1997 ; 231 : 130
28. 28 Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y et al. Regions in β chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996 ; 87 : 437
29. 29 Scarlatti G, Tresoldi E, Bjorndal A, Fredriksson R, Colognesi C, Deng HK et al. In vivo evolution of HIV-1 usage and sensitivity to chemokine-mediated suppression. Nat Med 1997 ; 3 : 1259
30. 30 Schmidt-Mayerova H, Sherry B, Bukrinsky M. Chemokines and HIV replication. Nature 1996 ; 382 : 67
31. 31 Schuitmaker H, Koot M, Koosta NA, Dercksen MW, de Goede REY, van Steenwijk RP et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell tropic virus populations. J Virol 1992 ; 66 : 1354
32. 32 Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997 ; 276 : 276
33. 33 Sol N, Ferhal F, Braun J, Pleskoff O, Treboute C, Ansart I et al. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J Virol 1997 ; 71 : 8237
34. 34 Solari R, Offord RE, Remy S, Aubry JP, Wells TNC, Whitehorn E et al. Receptor-mediated endocytosis of CC-chemokines. J Biol Chem 1997 ; 272 : 9617
35. 35 Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5. Nature 1996 ; 384 : 184
36. 36 Verani A, Scarlatti G, Comar M, Tresoldi E, Polo S, Giacca M et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T Cells. J Exp Med 1997 ; 5 : 805
37. 37 Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996 ; 384 : 179
38. 38 Yi Y, Rana S, Turner JD, Gaddis N, Collman RG. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 1998 ; 72 : 772
39. 39 Ylisastigui L, Vizzavona J, Drakopoulou E, Paindavoine P, Calvo CF, Parmentier M et al. Synthetic full-length and truncated RANTES inhibit human immunodeficiency virus type 1 infection of primary macrophages. AIDS 1998 ; 12 : 977-84
40. 40 Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF et al. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998 ; 95 : 3857
41. 41 Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993 ; 261 : 1179